{
    "organizations": [],
    "uuid": "423311216038eefd00944216305d4e92540bfae6",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-insys-therapeutics-reports-first-q/brief-insys-therapeutics-reports-first-quarter-2018-results-idUSASC0A0KR",
    "ord_in_thread": 0,
    "title": "BRIEF-Insys Therapeutics Reports First Quarter 2018 Results",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 8 (Reuters) - INSYS Therapeutics Inc:\n* Q1 REVENUE VIEW $25.7 MILLION — THOMSON REUTERS I/B/E/S * Q1 EARNINGS PER SHARE VIEW $-0.18 — THOMSON REUTERS I/B/E/S\n* Q1 ADJUSTED LOSS PER SHARE $0.19 * NET REVENUE IN Q1 WAS $23.9 MILLION Source text for Eikon: Further company coverage:\n ",
    "published": "2018-05-09T06:46:00.000+03:00",
    "crawled": "2018-05-09T12:55:06.026+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "reuters",
        "insys",
        "therapeutic",
        "inc",
        "q1",
        "revenue",
        "view",
        "million",
        "thomson",
        "reuters",
        "q1",
        "earnings",
        "per",
        "share",
        "view",
        "thomson",
        "reuters",
        "q1",
        "adjusted",
        "loss",
        "per",
        "share",
        "net",
        "revenue",
        "q1",
        "million",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}